z-logo
Premium
Gastric cancer screening and subsequent risk of gastric cancer: A large‐scale population‐based cohort study, with a 13‐year follow‐up in Japan
Author(s) -
Lee KyungJae,
Inoue Manami,
Otani Tetsuya,
Iwasaki Motoki,
Sasazuki Shizuka,
Tsugane Shoichiro
Publication year - 2005
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.21664
Subject(s) - medicine , cancer , prospective cohort study , population , cohort , gastroenterology , relative risk , incidence (geometry) , cohort study , stomach cancer , confidence interval , physics , environmental health , optics
We prospectively investigated the association between gastric cancer screening and subsequent risk of gastric cancer in a large‐scale population‐based prospective cohort study, with a 13‐year follow‐up in Japan. Data were analyzed from a population‐based cohort of 42,150 (20,326 men and 21,824 women) subjects. Approximately 36% of subjects reported that they had undergone screening photofluorography during the preceding 12 months, and were regarded as the screened group. A total of 179 gastric cancer deaths and 636 incident gastric cancers were identified during the follow‐up period. We observed a 2‐fold decrease in gastric cancer mortality in screened versus unscreened subjects (RR = 0.52; 95% CI = 0.36–0.74). The extent of the reduction in mortality for gastric cancer was greater than in death from all causes excluding gastric cancer (RR = 0.71; 95% CI = 0.65–0.78). A significant decrease in the incidence of advanced gastric cancer was observed in screened subjects (RR = 0.75; 95% CI = 0.58–0.96), although the overall incidence rate did not differ significantly between the screened and unscreened subjects (RR = 1.06; 95% CI = 0.90–1.25). In age‐stratified analyses, a significant reduction in gastric cancer mortality was seen in screened subjects aged 40–49 years at baseline, compared with a lesser reduction in screened subjects aged 50–59 (RR = 0.30, 95% CI = 0.13–0.72; and RR = 0.60, 95% CI = 0.40–0.88, respectively). These findings suggest that gastric cancer screening may be associated with a reduced risk of mortality from gastric cancer. © 2005 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom